PAOLINI, STEFANIA
PAOLINI, STEFANIA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
S. Paolini; PAOLINI S.; Stefania Paolini
[Molecular biology in myelodysplastic syndromes and acute myeloid leukemias "smoldering"]
2014 Martinelli, Giovanni; Sartor, Chiara; Papayannidis, Cristina; Iacobucci, Ilaria; Paolini, Stefania; Clissa, Cristina; Ottaviani, Emanuela; Finelli, Carlo
A germline polymorphism in the ANRIL (CDKN2BAS) locus is associated with susceptibility to Philadelphia-positive acute lymphoblastic leukemia (ALL)
2011 Anna Ferrari, Ilaria Iacobucci, Marco Sazzini, Annalisa Lonetti, Alessio Boattini, Cristina Papayannidis, Mariachiara Abbenante, Vilma Mantovani, Viviana Guadagnuolo, Federica Cattina, Elena Marasco, Emanuela Ottaviani, Stefania Paolini, Domenico Girelli, Simona Soverini, Michele Baccarani, Giovanni Martinelli
A HIGH SENSITIVE NANOFLUIDIC ARRAY IMPROVES THE DETECTION OF RARE COPIES OF BCR-ABL1 TRANSCRIPT IN PATIENTS WITH PHILADELPHIA POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
2010 Lonetti A; Iacobucci I; Ferrari A; Papayannidis C; Paolini S; Cilloni D; Abbenante M; Guadagnuolo V; Pane F; Baccarani M; Martinelli G
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
2023 Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casalin, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1
2015 Viviana Guadagnuolo, Cristina Papayannidis, Ilaria Iacobucci, Giorgia Simonetti, Antonella Padella, Stefania Paolini, Mariachiara Abbenante, Sarah Parisi, Francesca Volpato, Chiara Sartor, Maria Chiara Fontana, Massimo Delledonne, Michele Malagola, Carla Filì, Domenico Russo, Sandro Grilli, Michele Cavo, Giovanni Martinelli
A NEW SUBSET OF ADULT B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENT WITH PREDNISONE-INDUCED MONOCYTIC DIFFERENTIATION?
2009 Papayannidis C.; Iacobucci I.; Testoni N.; Baldazzi C.; Lonetti A.; Ottaviani E.; Guadagnuolo V.; Ferrari A.; Curti A.; Paolini S.; Abbenante M.; Bandini G.; Baccarani M.; Martinelli G.
A phase I study of Tipifarnib and Bortezomib in the treatment of poor risk adult acute myeloid leukemia (AML)
2014 Cristina Papayannidis, Stefania Paolini, Barbara Lama, Emanuela Ottaviani, Federica Salmi, Ilaria Iacobucci, Antonio Curti, Daniela Cilloni, Sarah Parisi, Giuseppe Saglio, Renato Fanin, Fortunato Morabito, Maria Pantaleo, Pier Luigi Lollini, Michele Baccarani, Giovanni Martinelli
A POLYMORPHISM IN THE CHROMOSOME 9P21 ANRIL LOCUS IS ASSOCIATED TO PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA SUSCEPTIBILITY
2010 Iacobucci I; Sazzini M; Ferrari A; Lonetti A; Boattini A; Papayannidis C; Garagnani P; Abbenante M; Mantovani V; Marasco E; Ottaviani E; Paolini S; Guadagnuolo V; Girelli D; Vignetti M; Pane F; Soverini S; Baccarani M; Martinelli G
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
2006 Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cilloni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
2012 Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Manzoli L.; Finelli C.; Cocco L.
ACTIVATION-INDUCED CYTIDINE DEAMINASE IS ABERRANTLY OVEREXPRESSED IN BCRABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND PROMOTES DNA-SINGLE STRAND BREAKS
2008 Iacobucci I; Lonetti A;; Ferrari A; Soverini S; Ottaviani E; Testoni N; Colarossi S; Salmi F; Gnani A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F;; Pane F; Vitale A; Chiaretti S; Saglio G; Foà R; Baccarani M; Martinelli G
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization
2017 Anna Ferrari, Valentina Robustelli, Eugenio Fonzi, Andrea Ghelli Luserna Di Rora, Marco Manfrini, Cristina Papayannidis, Stefania Paolini, Italo Valle, Vincenza Solli, Antonella Padella, Giorgia Simonetti, Giulia Ferrari, Margherita Perricone, Enrica Imbrogno, Sarah Parisi, Mariachiara Abbenante, Giovanni Marconi, Chiara Sartor, Nicoletta Testoni, Daniel Remondini, Michele Cavo, Giovanni Martinelli
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML)
2016 Marconi, Giovanni; Papayannidis, Cristina; Fontana, MARIA CHIARA; Padella, Antonella; Simonetti, Giorgia; Manfrini, Marco; Ferrari, Anna; Franchini, Eugenia; Paolini, Stefania; Parisi, Sarah; Sartor, Chiara; Abbenante, Mariachiara; LO MONACO, Silvia; Volpato, Francesca; Tenti, Elena; Guadagnuolo, Viviana; Perricone, Margherita; Bochicchio, MARIA TERESA; GHELLI LUSERNA DI RORÀ, Andrea; Baldazzi, Carmen; Robustelli, Valentina; Testoni, Nicoletta; Soverini, Simona; Ottaviani, Emanuela; Martinelli, Giovanni
ALTERNATIVE SPLICING OF IKAROS mRNA IS RESPONSIBLE FOR THE EXPRESSION OF DIFFERENT ABERRANT ISOFORMS IN PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) PATIENTS
2008 A. Lonetti; I. Iacobucci; R. Zuntini; S. Ferrari; D. Cilloni; F. Messa; E. Ottaviani; F. Arruga; F. Salmi; S. Paolini; C. Papayannidis; P.P. Piccaluga; P. Giannoulia; S. Soverini; G. Saglio; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia
2022 Ravaioli F.; Marconi G.; Martinelli G.; Dajti E.; Sartor C.; Abbenante M.C.; Alemanni L.V.; Nanni J.; Rossini B.; Parisi S.; Colecchia L.; Cristiano G.; Marasco G.; Vestito A.; Paolini S.; Bonifazi F.; Curti A.; Festi D.; Cavo M.; Colecchia A.; Papayannidis C.
At the time of diagnosis, Ph cells from both chronic phase chronic myeloid leukemia and acute lymphoblastic leukemia patients already harbour BCR-ABL kinase domain mutations
2009 Soverini S; Poerio A; Vitale A; Gnani A; Colarossi S; Castagnetti F.; Iacobucci I; Lonetti A; Palandri F; Rosti G; Amabile M; Paolini S; Papayannidis C; Gugliotta G; Vignetti M; Mandelli F; Baccarani M; Foà R; Martinelli G
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES
2011 Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS
2013 Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS
2012 Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study
2010 Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| [Molecular biology in myelodysplastic syndromes and acute myeloid leukemias "smoldering"] | Martinelli, Giovanni; Sartor, Chiara; Papayannidis, Cristina; Iacobucci, Ilaria; Paolini, Stefani...a; Clissa, Cristina; Ottaviani, Emanuela; Finelli, Carlo | 2014-01-01 | RECENTI PROGRESSI IN MEDICINA | - | 1.01 Articolo in rivista | - |
| A germline polymorphism in the ANRIL (CDKN2BAS) locus is associated with susceptibility to Philadelphia-positive acute lymphoblastic leukemia (ALL) | Anna Ferrari, Ilaria Iacobucci, Marco Sazzini, Annalisa Lonetti, Alessio Boattini, Cristina Papay...annidis, Mariachiara Abbenante, Vilma Mantovani, Viviana Guadagnuolo, Federica Cattina, Elena Marasco, Emanuela Ottaviani, Stefania Paolini, Domenico Girelli, Simona Soverini, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| A HIGH SENSITIVE NANOFLUIDIC ARRAY IMPROVES THE DETECTION OF RARE COPIES OF BCR-ABL1 TRANSCRIPT IN PATIENTS WITH PHILADELPHIA POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) | Lonetti A; Iacobucci I; Ferrari A; Papayannidis C; Paolini S; Cilloni D; Abbenante M; Guadagnuolo... V; Pane F; Baccarani M; Martinelli G | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes | Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casali...n, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y | 2023-01-01 | CLINICAL EPIGENETICS | - | 1.01 Articolo in rivista | - |
| A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 | Viviana Guadagnuolo, Cristina Papayannidis, Ilaria Iacobucci, Giorgia Simonetti, Antonella Padell...a, Stefania Paolini, Mariachiara Abbenante, Sarah Parisi, Francesca Volpato, Chiara Sartor, Maria Chiara Fontana, Massimo Delledonne, Michele Malagola, Carla Filì, Domenico Russo, Sandro Grilli, Michele Cavo, Giovanni Martinelli | 2015-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| A NEW SUBSET OF ADULT B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENT WITH PREDNISONE-INDUCED MONOCYTIC DIFFERENTIATION? | Papayannidis C.; Iacobucci I.; Testoni N.; Baldazzi C.; Lonetti A.; Ottaviani E.; Guadagnuolo V.;... Ferrari A.; Curti A.; Paolini S.; Abbenante M.; Bandini G.; Baccarani M.; Martinelli G. | 2009-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| A phase I study of Tipifarnib and Bortezomib in the treatment of poor risk adult acute myeloid leukemia (AML) | Cristina Papayannidis, Stefania Paolini, Barbara Lama, Emanuela Ottaviani, Federica Salmi, Ilaria... Iacobucci, Antonio Curti, Daniela Cilloni, Sarah Parisi, Giuseppe Saglio, Renato Fanin, Fortunato Morabito, Maria Pantaleo, Pier Luigi Lollini, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| A POLYMORPHISM IN THE CHROMOSOME 9P21 ANRIL LOCUS IS ASSOCIATED TO PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA SUSCEPTIBILITY | Iacobucci I; Sazzini M; Ferrari A; Lonetti A; Boattini A; Papayannidis C; Garagnani P; Abbenante ...M; Mantovani V; Marasco E; Ottaviani E; Paolini S; Guadagnuolo V; Girelli D; Vignetti M; Pane F; Soverini S; Baccarani M; Martinelli G | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. | Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cill...oni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G | 2006-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients | Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. | 2012-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| ACTIVATION-INDUCED CYTIDINE DEAMINASE IS ABERRANTLY OVEREXPRESSED IN BCRABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND PROMOTES DNA-SINGLE STRAND BREAKS | Iacobucci I; Lonetti A;; Ferrari A; Soverini S; Ottaviani E; Testoni N; Colarossi S; Salmi F; Gna...ni A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F;; Pane F; Vitale A; Chiaretti S; Saglio G; Foà R; Baccarani M; Martinelli G | 2008-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization | Anna Ferrari, Valentina Robustelli, Eugenio Fonzi, Andrea Ghelli Luserna Di Rora, Marco Manfrini,... Cristina Papayannidis, Stefania Paolini, Italo Valle, Vincenza Solli, Antonella Padella, Giorgia Simonetti, Giulia Ferrari, Margherita Perricone, Enrica Imbrogno, Sarah Parisi, Mariachiara Abbenante, Giovanni Marconi, Chiara Sartor, Nicoletta Testoni, Daniel Remondini, Michele Cavo, Giovanni Martinelli | 2017-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) | Marconi, Giovanni; Papayannidis, Cristina; Fontana, MARIA CHIARA; Padella, Antonella; Simonetti, ...Giorgia; Manfrini, Marco; Ferrari, Anna; Franchini, Eugenia; Paolini, Stefania; Parisi, Sarah; Sartor, Chiara; Abbenante, Mariachiara; LO MONACO, Silvia; Volpato, Francesca; Tenti, Elena; Guadagnuolo, Viviana; Perricone, Margherita; Bochicchio, MARIA TERESA; GHELLI LUSERNA DI RORÀ, Andrea; Baldazzi, Carmen; Robustelli, Valentina; Testoni, Nicoletta; Soverini, Simona; Ottaviani, Emanuela; Martinelli, Giovanni | 2016-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| ALTERNATIVE SPLICING OF IKAROS mRNA IS RESPONSIBLE FOR THE EXPRESSION OF DIFFERENT ABERRANT ISOFORMS IN PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) PATIENTS | A. Lonetti; I. Iacobucci; R. Zuntini; S. Ferrari; D. Cilloni; F. Messa; E. Ottaviani; F. Arruga; ...F. Salmi; S. Paolini; C. Papayannidis; P.P. Piccaluga; P. Giannoulia; S. Soverini; G. Saglio; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli | 2008-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia | Ravaioli F.; Marconi G.; Martinelli G.; Dajti E.; Sartor C.; Abbenante M.C.; Alemanni L.V.; Nanni... J.; Rossini B.; Parisi S.; Colecchia L.; Cristiano G.; Marasco G.; Vestito A.; Paolini S.; Bonifazi F.; Curti A.; Festi D.; Cavo M.; Colecchia A.; Papayannidis C. | 2022-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cancer Medicine - 2022 - Ravaioli - Assessment of liver stiffness measurement and ultrasound findings change during.pdf; CAM4-11-618-s005.zip |
| At the time of diagnosis, Ph cells from both chronic phase chronic myeloid leukemia and acute lymphoblastic leukemia patients already harbour BCR-ABL kinase domain mutations | Soverini S; Poerio A; Vitale A; Gnani A; Colarossi S; Castagnetti F.; Iacobucci I; Lonetti A; Pal...andri F; Rosti G; Amabile M; Paolini S; Papayannidis C; Gugliotta G; Vignetti M; Mandelli F; Baccarani M; Foà R; Martinelli G | 2009-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES |
Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L; Baccarani M |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS |
Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M |
2013-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS |
Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenan...te MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M |
2012-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study | Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |